Yet, it remains elusive whether clear cell meningioma is merely a morphological variant (albeit with prognostic implications) that can in principle be associated with various driving alterations, or whether the predominance of SMARCE1 alterations rather points to a defining set of molecular underpinnings unique to these tumors. This evidence concerns the gene SMARCE1 and meningioma.